BBlogFlow

Women Report More Pain Than Men Across 11 Parts of the Body, Study Finds - Yahoo

·1d ago

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

Headaches. Back pain. Abdominal pain. Knee pain. Across every body site researchers examined, women reported pain more often than men. That pattern emerged from a new Nature Medicine analysis of 6.1 million people across 118 countries, making it one of the largest attempts yet to map how pain is reported around the world. The differences were especially striking for some types of pain. Women were 83% more likely than men to report facial pain, 74% more likely to report headaches and 60% more likely to report abdominal pain. Six Million People Reveal A PatternPublished in Nature Medicine, the analysis brought together individual-level pain data from 6,125,459 people, drawn from 902 population-based sources covering 118 countries and territories. Researchers looked at 11 body sites, including the head, face, neck and shoulder, chest, back, abdomen, hip, knee, elbow, hand and wrist, and foot and ankle. Women were more likely than men to report pain at all 11 sites. The difference was not small everywhere. Depending on the location, women had between 1.08 and 1.83 times the likelihood of reporting pain compared with men.

This article is an excerpt. To read the full content, visit the original source. Yahoo

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·